|
DK590288D0
(da)
|
1988-10-24 |
1988-10-24 |
Symbicom Ab |
Kemiske forbindelser
|
|
AU530410B2
(en)
|
1978-02-21 |
1983-07-14 |
Sintef |
Preparing aqueous emulsions
|
|
US4281061A
(en)
|
1979-07-27 |
1981-07-28 |
Syva Company |
Double antibody for enhanced sensitivity in immunoassay
|
|
US4387164A
(en)
|
1980-11-05 |
1983-06-07 |
Fmc Corporation |
Method and apparatus for chemical analysis using reactive reagents dispersed in soluble film
|
|
NO155316C
(no)
|
1982-04-23 |
1987-03-11 |
Sintef |
Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
|
|
US4876190A
(en)
|
1987-10-21 |
1989-10-24 |
Becton Dickinson & Company |
Peridinin-chlorophyll complex as fluorescent label
|
|
US5039487A
(en)
|
1987-12-22 |
1991-08-13 |
Board Of Regents, The University Of Texas System |
Methods for quantifying components in liquid samples
|
|
DE68924850T2
(de)
|
1988-06-14 |
1996-10-10 |
Cell Med Inc |
Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
|
|
US6106840A
(en)
|
1988-06-23 |
2000-08-22 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US5260422A
(en)
|
1988-06-23 |
1993-11-09 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US5194425A
(en)
|
1988-06-23 |
1993-03-16 |
Anergen, Inc. |
Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
|
|
US5130297A
(en)
|
1988-06-23 |
1992-07-14 |
Anergen, Inc. |
Conjugates useful in ameliorating autoimmunity MHC-II-peptide
|
|
US5468481A
(en)
|
1988-06-23 |
1995-11-21 |
Amergen, Inc. |
MHC class II-peptide conjugates useful in ameliorating autoimmunity
|
|
DE3825615A1
(de)
|
1988-07-28 |
1990-02-01 |
Behringwerke Ag |
Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
|
|
DE4015911A1
(de)
|
1989-09-19 |
1991-03-28 |
Max Planck Gesellschaft |
Impfstoff gegen die lyme-krankheit
|
|
WO1991009870A1
(de)
|
1989-12-22 |
1991-07-11 |
Mikrogen Molekularbiologische Entwicklungs-Gmbh |
Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff
|
|
GB9007966D0
(en)
|
1990-04-09 |
1990-06-06 |
Dynal As |
Antigen/anti-antigen cleavage
|
|
CA2084413A1
(en)
|
1990-06-15 |
1991-12-16 |
Richard A. Flavell |
Compositions and methods for the prevention and diagnosis of lyme disease
|
|
IE76732B1
(en)
|
1990-08-07 |
1997-11-05 |
Becton Dickinson Co |
One step test for absolute counts
|
|
WO1994011078A1
(en)
|
1992-11-16 |
1994-05-26 |
Immunivest Corporation |
Magnetic immobilization and manipulation of biological entities
|
|
WO1992008983A1
(en)
|
1990-11-19 |
1992-05-29 |
Queen's University At Kingston |
Hiv marker/aids vaccine
|
|
CA2065658A1
(en)
|
1991-04-19 |
1992-10-20 |
Tse-Wen Chang |
Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
|
|
US6129916A
(en)
|
1991-04-19 |
2000-10-10 |
Tanox, Inc. |
Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
|
|
DE69232875T2
(de)
|
1991-04-23 |
2003-08-21 |
Anergen, Inc. |
MHC-Konjugate zur Verbesserung der Autoimmunität.
|
|
WO1992021972A1
(en)
|
1991-06-06 |
1992-12-10 |
Immulogic Pharmaceutical Corporation |
Rapid screening assay for the identification of ligand-receptor interactions
|
|
DK0594772T3
(da)
|
1991-07-04 |
1997-02-24 |
Immunodex K S |
|
|
US6872550B1
(en)
|
1991-07-11 |
2005-03-29 |
Baxter Vaccine Ag |
Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
|
|
DK0598816T3
(da)
|
1991-08-15 |
1999-11-22 |
Deutsches Krebsforsch |
Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner
|
|
DK0650527T3
(da)
|
1991-10-22 |
2003-07-14 |
Symbicom Ab |
Forbedring af Borrelia burgdorferidiagnose og -profylakse
|
|
WO1993010220A1
(en)
|
1991-11-19 |
1993-05-27 |
Anergen, Inc. |
Soluble mhc molecules and their uses
|
|
US5583031A
(en)
|
1992-02-06 |
1996-12-10 |
President And Fellows Of Harvard College |
Empty major histocompatibility class II heterodimers
|
|
EP0911036A3
(en)
|
1992-02-11 |
2001-05-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
JP3167415B2
(ja)
|
1992-04-30 |
2001-05-21 |
オリンパス光学工業株式会社 |
固相免疫検査における抗原細胞の保存方法
|
|
DE69332268T2
(de)
|
1992-10-15 |
2003-08-14 |
Toray Industries, Inc. |
Verfahren zur herstellung von rekombinant mhcii protein in mikroorganismen
|
|
DE69332884T2
(de)
|
1992-10-21 |
2003-11-20 |
Stefan Miltenyi |
Direkte auswahl von zellen durch ein aussheidungsprodukt
|
|
WO1994012196A1
(en)
|
1992-11-25 |
1994-06-09 |
Tanox Biosystems, Inc. |
Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules
|
|
US6090587A
(en)
|
1993-10-25 |
2000-07-18 |
Corixa Corporation |
Prokaryotic expression of MHC proteins
|
|
EP0725838A4
(en)
|
1993-10-26 |
1997-02-26 |
United Biomedical Inc |
STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS
|
|
WO2002016422A2
(en)
|
2000-08-18 |
2002-02-28 |
Research Foundation Of The State University Of New York |
Recombinant constructs of borrelia burgdorferi
|
|
CA2175567C
(en)
|
1993-11-01 |
2010-08-10 |
John J. Dunn |
Chimeric proteins comprising borrelia polypeptides: uses therefor
|
|
US5620862A
(en)
|
1993-11-24 |
1997-04-15 |
University Of Connecticut |
Methods for diagnosing early Lyme disease
|
|
CA2140591A1
(en)
|
1994-01-20 |
1995-07-21 |
Josef Endl |
Antigen-specific, activated t lymphocytes, detection and use
|
|
US7074904B2
(en)
|
1994-07-29 |
2006-07-11 |
Altor Bioscience Corporation |
MHC complexes and uses thereof
|
|
DE69534880T2
(de)
|
1994-07-29 |
2007-02-22 |
Sunol Molecular Corp., Miramar |
Mhc-komplexe und verwendungen davon
|
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
|
US20030118594A1
(en)
*
|
1995-06-07 |
2003-06-26 |
Bishwajit Nag |
Stable formulations of mhc-peptide complexes
|
|
WO1997005239A1
(en)
|
1995-07-25 |
1997-02-13 |
Celltherapy, Inc. |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
|
US5807552A
(en)
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
|
US6001964A
(en)
*
|
1995-09-20 |
1999-12-14 |
Albert Einstein College Of Medicine Of Yeshiva University |
Peptides which bind to anti-double stranded DNA antibody
|
|
US5869270A
(en)
|
1996-01-31 |
1999-02-09 |
Sunol Molecular Corporation |
Single chain MHC complexes and uses thereof
|
|
US6458354B1
(en)
|
1996-03-28 |
2002-10-01 |
The Johns Hopkins University |
Molecular complexes which modify immune responses
|
|
US6140113A
(en)
|
1996-03-28 |
2000-10-31 |
The Johns Hopkins University |
Polynucleotides encoding molecular complexes which modify immune responses
|
|
CA2250166A1
(en)
|
1996-03-28 |
1997-10-02 |
The Johns Hopkins University |
Soluble divalent and multivalent heterodimeric analogs of proteins
|
|
ATE232212T1
(de)
|
1996-05-02 |
2003-02-15 |
Dako As |
Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
|
|
AU3036597A
(en)
|
1996-05-21 |
1997-12-09 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
|
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
|
US6211342B1
(en)
|
1996-07-18 |
2001-04-03 |
Children's Hospital Medical Center |
Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
|
|
FR2751989B1
(fr)
|
1996-08-01 |
1998-10-30 |
Soc D Rech Et De Dev En Activa |
Methode d'identification de cellules eucaryotes par fixation desdites cellules sur un support et support pour mettre en oeuvre ladite methode
|
|
CA2262001C
(en)
|
1996-08-05 |
2003-05-20 |
President And Fellows Of Harvard College |
Mhc binding peptide oligomers and methods of use
|
|
NZ333915A
(en)
|
1996-08-16 |
2000-11-24 |
Harvard College |
Soluble monovalent and multivalent MHC class II fusion proteins
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US6074645A
(en)
|
1996-11-12 |
2000-06-13 |
City Of Hope |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
|
|
US6562345B1
(en)
|
1996-11-12 |
2003-05-13 |
City Of Hope |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
|
|
CA2271784A1
(en)
|
1996-11-12 |
1998-05-22 |
City Of Hope |
Immuno-reactive peptide ctl epitopes of human cytomegalovirus
|
|
US6156317A
(en)
|
1996-11-12 |
2000-12-05 |
City Of Hope |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
|
|
US6197928B1
(en)
|
1997-03-14 |
2001-03-06 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
|
US5998204A
(en)
|
1997-03-14 |
1999-12-07 |
The Regents Of The University Of California |
Fluorescent protein sensors for detection of analytes
|
|
US6268411B1
(en)
|
1997-09-11 |
2001-07-31 |
The Johns Hopkins University |
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
|
|
US5994089A
(en)
|
1997-05-16 |
1999-11-30 |
Coulter International Corp. |
Simultaneous analyses of white blood cell subsets using multi-color, multi-intensity fluorescent markers in flow cytometry
|
|
US5891741A
(en)
|
1997-05-16 |
1999-04-06 |
Coulter International Corp. |
Antibody-aminodextran-phycobiliprotein conjugates
|
|
EP1003548B1
(en)
|
1997-07-10 |
2006-05-10 |
Mannkind Corporation |
Device for inducing a ctl response
|
|
US6248564B1
(en)
|
1997-08-29 |
2001-06-19 |
Harvard University |
Mutant MHC class I molecules
|
|
GB9718463D0
(en)
|
1997-08-29 |
1997-11-05 |
Dynal As |
Biomolecules
|
|
ES2323098T3
(es)
|
1997-09-16 |
2009-07-06 |
Oregon Health And Science University |
Moleculas de mhc recombinantes utiles para la manipulacion de celulas t especificas de antigeno.
|
|
DE19740735A1
(de)
|
1997-09-16 |
1999-03-18 |
Max Planck Gesellschaft |
Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
|
|
US6232445B1
(en)
|
1997-10-29 |
2001-05-15 |
Sunol Molecular Corporation |
Soluble MHC complexes and methods of use thereof
|
|
NZ504951A
(en)
|
1997-11-10 |
2001-06-29 |
Statens Seruminstitut |
Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
|
|
ES2272074T3
(es)
|
1998-01-19 |
2007-04-16 |
Florian Kern |
Procedimiento para la identificacion de fragmentos proteicos estimuladores de celulas t.
|
|
IL137706A0
(en)
|
1998-02-19 |
2001-10-31 |
Harvard College |
Mhc fusion proteins and conjugates
|
|
WO1999050637A2
(en)
|
1998-03-27 |
1999-10-07 |
Ludwig Institute For Cancer Research |
Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof
|
|
EP0949508A1
(en)
|
1998-04-08 |
1999-10-13 |
Dako A/S |
Method, antigen complex and kit for diagnosing Lyme borreliosis
|
|
GB9810099D0
(en)
|
1998-05-11 |
1998-07-08 |
Isis Innovation |
Novel molecule and diagnostic method
|
|
WO1999060120A2
(en)
|
1998-05-19 |
1999-11-25 |
Avidex Limited |
Soluble t cell receptor
|
|
WO1999059633A1
(en)
|
1998-05-20 |
1999-11-25 |
Immunomedics, Inc. |
Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
|
|
DE69938183T2
(de)
|
1998-07-31 |
2009-02-19 |
Gundersen Lutheran Medical Foundation, Inc., La Crosse |
Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
|
|
MXPA01002674A
(es)
|
1998-09-14 |
2002-06-04 |
Ostergaard Pedersen Lars |
Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.
|
|
DE69918146T2
(de)
|
1998-10-05 |
2005-07-07 |
Pharmexa A/S |
Verfahren zur therapeutischen impfung
|
|
EP1135409A1
(en)
|
1998-10-09 |
2001-09-26 |
Medimmune, Inc. |
Decorin binding proteins dbp a and b and genes encoding them
|
|
WO2000023053A2
(en)
|
1998-10-20 |
2000-04-27 |
Salvatore Albani |
Artificial antigen-specific cells and related methods
|
|
ATE370967T1
(de)
|
1998-10-21 |
2007-09-15 |
Altor Bioscience Corp |
Polyspezifische bindemoleküle und deren verwendung
|
|
US6156514A
(en)
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US7116407B2
(en)
|
1998-12-15 |
2006-10-03 |
Union Biometrica, Inc. |
System for axial pattern analysis of multicellular organisms
|
|
US6335173B1
(en)
|
1999-01-12 |
2002-01-01 |
Verve, Ltd. C/O James Bell |
Methods for detecting an analyte of interest using tyramide coating technology
|
|
HK1041312B
(en)
|
1999-04-16 |
2006-09-29 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for the detection of antigen specific t-cells
|
|
US7041442B1
(en)
|
1999-06-04 |
2006-05-09 |
Florian Kern |
Peptides for vaccinating against human CMV
|
|
WO2000078966A1
(en)
|
1999-06-18 |
2000-12-28 |
Research Foundation Of State University Of New York |
Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
|
|
US20040209314A1
(en)
|
1999-09-06 |
2004-10-21 |
Institut National De La Sante Et De La Recherche Medicale France |
Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
|
|
US20030104635A1
(en)
|
1999-09-21 |
2003-06-05 |
Avidex Limited |
Screening methods
|
|
GB9922352D0
(en)
|
1999-09-21 |
1999-11-24 |
Avidex Ltd |
Screening method
|
|
US6632435B1
(en)
|
1999-10-20 |
2003-10-14 |
City Of Hope |
CTL epitope analogs
|
|
US6605711B1
(en)
|
1999-11-15 |
2003-08-12 |
Ludwig Institute For Cancer Research |
NY-ESO-1 peptide derivatives, and uses thereof
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US8609436B2
(en)
|
2000-03-17 |
2013-12-17 |
Guy's & St Thomas' Hospital NHS Trust (“GST”) |
Method
|
|
AU2001261005A1
(en)
|
2000-03-22 |
2001-10-03 |
Corixa Corporation |
Immune mediators and related methods
|
|
US6835383B2
(en)
|
2000-03-23 |
2004-12-28 |
City Of Hope |
Protein kinase deficient, immunologically active CMVpp65 mutants
|
|
AU2001249444A1
(en)
|
2000-03-28 |
2001-10-08 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Methods and compositions for the simultaneous detection of multiple analytes
|
|
WO2001080833A1
(en)
|
2000-04-20 |
2001-11-01 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
WO2001090198A1
(en)
|
2000-05-24 |
2001-11-29 |
Ludwig Institute For Cancer Research |
Multicomponent conjugates which bind to target molecules and stimulate cell lysis
|
|
EP1287363A2
(en)
|
2000-05-25 |
2003-03-05 |
Sunol Molecular Corporation |
Modulation of t-cell receptor interactions
|
|
US6517838B1
(en)
*
|
2000-06-16 |
2003-02-11 |
The Texas A&M University System |
Decorin binding protein essential peptides and methods of use
|
|
GB0018901D0
(en)
|
2000-08-03 |
2000-09-20 |
Biovation Ltd |
Peptides presented by cells
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
EP1227321A1
(en)
|
2000-12-28 |
2002-07-31 |
Institut für Bioanalytik GmbH |
Reversible MHC multimer staining for functional purification of antigen-specific T cells
|
|
EP1349569B1
(en)
|
2001-01-12 |
2007-04-18 |
Becton Dickinson and Company |
Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
|
|
US20020082411A1
(en)
|
2001-01-23 |
2002-06-27 |
Darrick Carter |
Immune mediators and related methods
|
|
ES2747357T3
(es)
|
2001-03-14 |
2020-03-10 |
Dako Denmark As |
Construcciones de moléculas MHC y sus usos para el diagnóstico y terapia
|
|
US7094555B2
(en)
|
2001-04-05 |
2006-08-22 |
Benaroya Research Institute At Virginia Mason |
Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
|
|
US20030199438A1
(en)
|
2001-04-09 |
2003-10-23 |
Shaw Allan Christian |
Method for identification of proteins from intracellular bacteria
|
|
DE10117858A1
(de)
|
2001-04-10 |
2002-10-24 |
Gsf Forschungszentrum Umwelt |
MHC-Tetramere
|
|
US6811785B2
(en)
|
2001-05-07 |
2004-11-02 |
Mount Sinai School Of Medicine Of New York University |
Multivalent MHC class II—peptide chimeras
|
|
US20040143094A1
(en)
|
2003-02-10 |
2004-07-22 |
Alena Donda |
Multicomponent conjugates which bind to target molecules and stimulate T cell lysis
|
|
US20040068100A1
(en)
|
2001-05-24 |
2004-04-08 |
Jean-Pierre Mach |
Multicomponent conjugates which bind to target molecules and stimulate cell lysis
|
|
AUPR593101A0
(en)
|
2001-06-26 |
2001-07-19 |
Council Of The Queensland Institute Of Medical Research, The |
Cytomegalovirus t cell epitopes
|
|
US7902121B2
(en)
|
2001-07-02 |
2011-03-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
MHC-antigen arrays for detection and characterization of immune responses
|
|
GB0120042D0
(en)
|
2001-08-16 |
2001-10-10 |
Avidex Ltd |
Methods
|
|
EP1483575A2
(en)
|
2002-02-28 |
2004-12-08 |
Intercell AG |
Methods for isolating ligands e.g. t cell epitopes
|
|
US8895020B2
(en)
|
2002-04-19 |
2014-11-25 |
Washington University |
Single chain trimers and uses therefor
|
|
AU2003230366A1
(en)
|
2002-05-08 |
2003-11-11 |
Northwest Biotherapeutics, Inc. |
Quality assays for antigen presenting cells
|
|
AU2003273577A1
(en)
|
2002-05-30 |
2003-12-19 |
Sloan Kettering Institute For Cancer Research |
Suicide tetramers comprising mhc class i and uses thereof
|
|
EP1539215A2
(en)
|
2002-06-25 |
2005-06-15 |
City of Hope |
Adjuvant-free peptide vaccine
|
|
JP4619121B2
(ja)
|
2002-08-12 |
2011-01-26 |
ザ カウンシル オブ ザ クイーンズランド インスティテュート オブ メディカル リサーチ |
Ｔヘルパーエピトープおよび細胞傷害性ｔリンパ球（ｃｔｌ）エピトープを含む新規な免疫原性リポペプチド
|
|
GB2392158B
(en)
|
2002-08-21 |
2005-02-16 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof
|
|
GB0222846D0
(en)
|
2002-10-03 |
2002-11-06 |
Choo Yen |
Cell culture
|
|
EP1549748B1
(en)
|
2002-10-09 |
2014-10-01 |
Immunocore Ltd. |
Single chain recombinant t cell receptors
|
|
DE10247014A1
(de)
|
2002-10-09 |
2004-04-22 |
Erfle, Volker, Prof. Priv.-Doz. Dr. |
MHC-Multimere
|
|
US20040072262A1
(en)
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
US20040223977A1
(en)
|
2003-02-03 |
2004-11-11 |
City Of Hope |
Fusion peptide HIV vaccines
|
|
DE10310261A1
(de)
|
2003-03-05 |
2004-09-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Identifizierung von Antigen-Epitopen
|
|
KR100818689B1
(ko)
|
2003-03-10 |
2008-04-02 |
도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 |
간엽계 간세포의 식별방법
|
|
US20060018878A1
(en)
|
2003-03-11 |
2006-01-26 |
City Of Hope |
Dual antigen specific T cells with trafficking ability
|
|
CA2520675A1
(en)
|
2003-03-24 |
2004-10-07 |
The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services |
Identification, quantification, and characterization of t cells and t cell antigens
|
|
US7163685B2
(en)
|
2003-04-16 |
2007-01-16 |
City Of Hope |
Human cytomegalovirus antigens expressed in MVA and methods of use
|
|
DK1635863T3
(da)
|
2003-06-17 |
2010-11-22 |
Mannkind Corp |
Sammensætninger til udløsning, forbedring og opretholdelse af immunresponser mod MHC-klasse-i-begrænsede epitoper til profylaktiske eller terapeutiske formål
|
|
AU2004254367B2
(en)
|
2003-06-27 |
2008-06-19 |
Nanosphere, Inc. |
Bio-barcode based detection of target analytes
|
|
ATE432285T1
(de)
|
2003-07-11 |
2009-06-15 |
Alphavax Inc |
Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
|
|
US7364869B2
(en)
|
2003-07-29 |
2008-04-29 |
The J. David Gladstone Institutes |
Method of detecting antigen-specific T lymphocytes
|
|
GB0318096D0
(en)
|
2003-08-01 |
2003-09-03 |
Queen Mary & Westfield College |
Vaccine
|
|
GB2408507B
(en)
|
2003-10-06 |
2005-12-14 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof for specific targeting
|
|
RU2260047C2
(ru)
|
2003-10-23 |
2005-09-10 |
Государственное учреждение Научно-исследовательский институт биохимии Сибирского отделения Российской академии медицинских наук |
Рекомбинантная плазмидная днк, обеспечивающая синтез иммунодоминантного белка borrelia garinii, используемого для диагностики лайм-боррелиоза (варианты)
|
|
US20050095655A1
(en)
|
2003-11-03 |
2005-05-05 |
Montero-Julian Felix A. |
Solution-based methods for detecting MHC-binding peptides
|
|
US8772451B2
(en)
|
2003-11-10 |
2014-07-08 |
Altor Bioscience Corporation |
Soluble TCR molecules and methods of use
|
|
ES2323588T3
(es)
|
2003-11-19 |
2009-07-21 |
Merck Patent Gmbh |
Proteinas que pertenecen a la familia bcl-2 y fragmentos de las mismas, y su uso en pacientes con cancer.
|
|
CA2544577C
(en)
|
2003-12-01 |
2013-01-08 |
Dako Denmark A/S |
Methods and compositions for immuno-histochemical detection
|
|
US7706782B1
(en)
|
2004-03-01 |
2010-04-27 |
Adobe Systems Incorporated |
System and method for developing information for a wireless information system
|
|
DE102004026135A1
(de)
|
2004-05-25 |
2006-01-05 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
WO2005115447A2
(en)
|
2004-05-25 |
2005-12-08 |
The Trustees Of The University Of Pennsylvania |
Human anti-cancer immunotherapy
|
|
EP1781313A4
(en)
|
2004-06-17 |
2009-08-26 |
Beckman Coulter Inc |
MYCOBACTERIUM TUBERCULOSIS EPITOPES AND METHODS OF USE
|
|
WO2006014292A2
(en)
|
2004-07-02 |
2006-02-09 |
Dattwyler Raymond J |
Oral vaccine for borrelia
|
|
US20060228758A1
(en)
|
2004-09-13 |
2006-10-12 |
Xencor, Inc. |
Analysis of MHC-peptide binding interactions
|
|
WO2006031883A2
(en)
|
2004-09-13 |
2006-03-23 |
Xencor, Inc. |
Analysis of mhc-peptide binding interactions
|
|
US20060228759A1
(en)
|
2004-09-13 |
2006-10-12 |
Xencor, Inc. |
Analysis of MHC-peptide binding interactions
|
|
DE102004054545A1
(de)
|
2004-09-16 |
2006-04-06 |
Max-Delbrück-Centrum für Molekulare Medizin |
Änderung des Beladungszustandes von MHC-Molekülen
|
|
US7976845B2
(en)
|
2004-11-29 |
2011-07-12 |
The Council Of The Queensland Institute Of Medical Research |
Human cytomegalovirus immunotherapy
|
|
EP1838342A2
(en)
|
2004-12-29 |
2007-10-03 |
Mannkind Corporation |
Methods to bypass cd+4 cells in the induction of an immune response
|
|
CA2593714C
(en)
|
2005-02-04 |
2013-09-10 |
Survac Aps |
Survivin peptide vaccine
|
|
GB2422834B8
(en)
|
2005-02-04 |
2007-01-04 |
Proimmune Ltd |
MHC oligomer and method of making the same
|
|
US8541227B2
(en)
|
2005-02-25 |
2013-09-24 |
Dako Denmark A/S |
Cell counting
|
|
KR100677572B1
(ko)
|
2005-04-04 |
2007-02-02 |
삼성전자주식회사 |
전자사진방식 화상형성장치 및 현상방법
|
|
US20090130144A1
(en)
|
2005-04-15 |
2009-05-21 |
University Of Maryland, Baltimore |
Direct vaccination of the bone marrow
|
|
ATE501277T1
(de)
|
2005-07-01 |
2011-03-15 |
Dako Denmark As |
Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffen
|
|
US7468186B2
(en)
|
2005-07-22 |
2008-12-23 |
City Of Hope |
Polyomavirus cellular epitopes and uses therefor
|
|
JP5390189B2
(ja)
|
2005-11-29 |
2014-01-15 |
ヴァージニア コモンウェルス ユニバーシティ |
多価キメラｏｓｐｃワクシノーゲンおよび診断用抗原
|
|
US7502580B2
(en)
|
2005-11-30 |
2009-03-10 |
Xerox Corporation |
Two component development system using ion or electron charged toner
|
|
US20070134814A1
(en)
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
|
US20090061478A1
(en)
|
2006-01-30 |
2009-03-05 |
Lene Have Poulsen |
High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry
|
|
US8518697B2
(en)
|
2006-04-04 |
2013-08-27 |
Washington University |
Single chain trimers and uses therefor
|
|
WO2007136778A2
(en)
|
2006-05-19 |
2007-11-29 |
Teva Pharmaceutical Industries, Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
|
US20080171059A1
(en)
|
2006-08-07 |
2008-07-17 |
Shanshan Wu Howland |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
WO2008031133A2
(en)
|
2006-09-15 |
2008-03-20 |
Intercell Ag |
Borrelia antigens
|
|
WO2008116468A2
(en)
|
2007-03-26 |
2008-10-02 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
|
US20090004213A1
(en)
|
2007-03-26 |
2009-01-01 |
Immatics Biotechnologies Gmbh |
Combination therapy using active immunotherapy
|
|
WO2009003493A2
(en)
|
2007-07-03 |
2009-01-08 |
Dako Denmark A/S |
Mhc multimers, methods for their generation, labeling and use
|
|
US10611818B2
(en)
|
2007-09-27 |
2020-04-07 |
Agilent Technologies, Inc. |
MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
US8815564B2
(en)
|
2008-03-14 |
2014-08-26 |
Sanofi Pasteur Biologics, Llc |
Replication-defective flavivirus vaccines and vaccine vectors
|
|
CN102112626A
(zh)
|
2008-04-09 |
2011-06-29 |
加州理工学院 |
用于检测和/或分类靶标的捕获剂以及相关方法和系统
|
|
WO2009126816A1
(en)
|
2008-04-09 |
2009-10-15 |
Ventria Bioscience |
Production of ospa for lyme disease control
|
|
EP2281007B1
(en)
|
2008-04-10 |
2014-07-09 |
Thrombosis Research Institute |
Anti-atheroma vaccine
|
|
US20090324630A1
(en)
|
2008-04-21 |
2009-12-31 |
Jensen Michael C |
Fusion multiviral chimeric antigen
|
|
FR2931163B1
(fr)
|
2008-05-16 |
2013-01-18 |
Ets Francais Du Sang |
Lignee de cellules dendritiques plasmacytoides utilisee en therapie cellulaire active ou adoptive
|
|
EP3156069B8
(en)
|
2008-06-20 |
2020-10-21 |
Duke University |
Compositions, methods, and kits for eliciting an immune response
|
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
|
GB0817244D0
(en)
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|